Literature DB >> 14568821

Aicardi syndrome.

Tena Rosser1.   

Abstract

The astute observations of Aicardi and colleagues led to the first description of Aicardi syndrome as a triad of infantile spasms, absence of the corpus callosum, and chorioretinal lacunae. Still diagnosed clinically, we now recognize an expanded version of this probable X-linked dominant disorder that predominantly affects females. In addition to the classic findings, patients typically experience intractable epilepsy of multiple seizure types, profound mental retardation, and costovertebral anomalies. Associated cerebral and ophthalmologic malformations are numerous. This article highlights several seminal citations involving the history of the initial description and the characteristic ophthalmologic and electroencephalographic features of Aicardi syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 14568821     DOI: 10.1001/archneur.60.10.1471

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Ophthalmologic findings in Aicardi syndrome.

Authors:  Gary Fruhman; Tanya N Eble; Nikki Gambhir; V Reid Sutton; Ignatia B Van den Veyver; Richard A Lewis
Journal:  J AAPOS       Date:  2012-06       Impact factor: 1.220

2.  Aicardi syndrome associated with autosomal genomic imbalance: coincidence or evidence for autosomal inheritance with sex-limited expression?

Authors:  P Prontera; A Bartocci; V Ottaviani; I Isidori; D Rogaia; C Ardisia; G Guercini; A Mencarelli; E Donti
Journal:  Mol Syndromol       Date:  2013-04-11

3.  Late Presentation of Retinoblastoma in a Teen with Aicardi Syndrome.

Authors:  Patricia Y Akinfenwa; Patricia Chévez-Barrios; Clio A Harper; Dan S Gombos
Journal:  Ocul Oncol Pathol       Date:  2016-02-02

4.  Agenesis of the corpus callosum in fetuses with mild ventriculomegaly: role of MR imaging.

Authors:  R Manfredi; A Tognolini; C Bruno; R Raffaelli; M Franchi; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2009-12-16       Impact factor: 3.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.